IRCT20190729044372N1已完成2 期
Comparing efficacy of Rivaroxaban versus Warfarin on carotid plaque in NVAF patients
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Non -valve artrial fibrillation with stroke or TIA or IF<30%
- •Not taking Asprin
- •Lack of kidney and liver diseases and other specific disease
排除标准
- •Having a heart valve disorder
- •Taking Asprin
研究者
相似试验
招募中
3 期
Efficacy and safety of rivaroxaban and subcutaneous enoxaparin after spinal surgeryIntravenous thromboembolism.Thromboembolism in the puerperiumO88.23IRCT20211109053014N1Esfahan University of Medical Sciences200
招募中
3 期
Rivaroxaban in Left Ventricular ThrombusIRCT20181022041406N4Rajaie cardiovascular medical and research center50
招募中
2 期
Efficiency of rivaroxaban and enoxaparin in the prevention of venous thromboembolic eventsSpinal fusion.Osseous stenosis of neural canalM99.3IRCT20120527009878N16Tabriz University of Medical Sciences60
已完成
2 期
Effect of rivaroxaban in radial artery thrombosisIRCT20200111046084N1Rajaie Cardiovascular Medical and Research Center40
已完成
3 期
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationEmbolismStrokeAtrial FibrillationNCT00403767Johnson & Johnson Pharmaceutical Research & Development, L.L.C.14,269